Ann: Clinical Trial Preliminary Outcomes, page-126

My guess for tomorrow is a gap up on open, followed by a bit of a rise, followed by a retrace. I think there will be significant media coverage overnight and that will cause early interest.

MC is still waaaay too low. But experience tells me there will be profit taking at some point. Longer term the price will be higher, but it won't go up in a straight line.

Another thing to consider is that NTI should no be a take-over target. If they can show significant improvements in autism symptoms then there would be several BioTech giants who would be interested.